What is Roivant Sciences's increase decrease in interest payable net?

Roivant Sciences (ROIV) reported increase decrease in interest payable net of $0 in Q1 2026.

What is the long-term trend for Roivant Sciences's increase decrease in interest payable net?

Over 3 years (2022 to 2025), Roivant Sciences's increase decrease in interest payable net has grown at a -100.0% compound annual growth rate (CAGR), from $18.57M to $0.

Roivant Sciences ROIV Increase Decrease In Interest Payable Net

Other financials

Income statement

See full

Revenue$2.5M-66.7%

Balance sheet

See full

Cash & equivalents$1.4B+1,411%

Total debt$107.4M+7.3%

Total equity$4.5B-3.4%

Total assets$5.7B+5.0%

Cash flow

See full

Operating cash flow-$163.8M+5.1%

CapEx$1.3M+55.5%

Free cash flow-$165.1M+4.8%

Valuation

See full

Market cap$22.61B+175%

Enterprise value$21.29B+157%

P/S2,736.9×+2,454×

Profitability

See full

Operating margin-9,130.5%-13,995pp

Net margin-6,079.9%-6,193pp

Returns & leverage

See full

Return on equity-17.1%-17.7pp

Debt / equity0×0.0×

Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInterestPayableNet.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Roivant Sciences's increase decrease in interest payable net?: Roivant Sciences (ROIV) reported increase decrease in interest payable net of $0 in Q1 2026.
What is the long-term trend for Roivant Sciences's increase decrease in interest payable net?: Over 3 years (2022 to 2025), Roivant Sciences's increase decrease in interest payable net has grown at a -100.0% compound annual growth rate (CAGR), from $18.57M to $0.